GlassScriptPhysician profile
Thanh Nguyen
NPI 1518967090
$3,013.88
in general payments reported to CMS, 2019-2025
26 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $302 · 2021: $259 · 2022: $305 · 2023: $762 · 2024: $431 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $569.23 | 2019-2023 | Tria Firm, Rezum Generator, Lithoclast |
| Astellas Pharma US INC | $544.29 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| C. R. Bard, INC. & Subsidiaries | $248.05 | 2019-2023 | |
| Neotract INC. | $235.33 | 2019 | |
| Healthtronics Stone Solutions, LLC | $172.59 | 2019-2022 | |
| Travere Therapeutics, INC. | $143.93 | 2020-2024 | |
| Coloplast Corp | $136.52 | 2020-2025 | Speedicath |
| Sumitomo Pharma America, INC. | $132.65 | 2023-2024 | Gemtesa, Orgovyx |
| Olympus America INC. | $125.00 | 2020 | |
| Teleflex LLC | $121.37 | 2021-2024 | Urolift |
| Abbvie INC. | $86.33 | 2023-2025 | |
| 180 Medical, INC. | $75.58 | 2019-2023 | |
| Antares Pharma, INC. | $52.95 | 2021-2023 | Xyosted, Tlando, Nocdurna |
| Acerus Pharmaceuticals Corporation | $51.82 | 2020-2021 | |
| Procept Biorobotics Corporation | $47.26 | 2022-2024 | Aquabeam System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $40.55 | 2024-2025 | Jatenzo, Eligard |
| Amgen INC. | $39.72 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $25.65 | 2024 | Adstiladrin |
| Merck Sharp & Dohme LLC | $25.27 | 2024 | Keytruda |
| Endo Pharmaceuticals INC. | $24.21 | 2019 | |
| Axonics, INC. | $23.72 | 2024 | Axonics |
| Eisai INC. | $23.51 | 2023 | |
| Cook Medical LLC | $18.99 | 2024 | Ncircle |
| Acera Surgical, INC. | $18.65 | 2025 | Restrata Wound Matrix |
| Urovant Sciences INC | $16.85 | 2021 | |
| Pfizer INC. | $13.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thanh Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.